Percutaneous interventions in the coagulopathic patient

Seminars in Interventional Radiology

Volumn 22, Issue 2, 2005, Pages 88-94

  Konkle, Barbara A ^a,b  

^a MAB 103 ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Coagulopathy; Complications; Interventional radiology; Review; Thrombocytopenia

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; FIBRIN GLUE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSEEL VH; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ANTICOAGULATION; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; HEMOPHILIA; HUMAN; INTERVENTIONAL RADIOLOGY; REVIEW; RISK FACTOR; SCREENING; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

EID: 21744462909     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871863     Document Type: Review

References (31)

1. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hematol 990;16:1-20
2. Favaloro EJ. Clinical application of the PFA-100. Curr Opin Hematol 2002;9:407-415
3. Liu MC, Kessler CM. A systematic approach to the bleeding patient. In: Kitchens CS, Alving BA, Kessler CM, eds. Consultative Hemostasis and Thrombosis. Philadelphia: WB Saunders; 2002:27-39
4. Rao AK. Acquired qualitative platelet defects. In: Colman RW, Marder VJ, Clowes P, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:905-920
5. Stanworth SJ, Brunskill SJ, Hyde CH, McClelland DBL, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004;126:139-152
6. McVay PA, Toy PTCY. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 1990;94:747-753
7. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy-a prospective audit. Intensive Care Med 1999;25:481-485
8. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991;31:164-171
9. Chowdhury P, Saayman AG, Paulua U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004;125:69-73
10. Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 2003;98:1391-1394
11. Kuriyan M, Carson JL. Blood transfusion risks in the intensive care unit. Crit Care Clin 2004;20:237-253
12. Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004; 18:153-167
13. Wallace MJ, Narvios A, Lichtiger B, et al. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol 2003;14:323-327
14. Vavricka SR, Walter RB, Irani S, Halter J, Schanz U. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion. Ann Hematol 2003;82:570-573
15. Ray CE Jr, Shenoy SS. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 1997;204:97-99
16. Kitchens CS: Surgery and hemostasis. In: Kitchens CS, Alving BA, Kessler CM, eds. Consultative Hemostasis and Thrombosis. Philadelphia: WB Saunders; 2002:463-480
17. Aster RH. Pooling of platelet in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966;45:645-657
18. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997;90:2515-2521
19. Rao AK, Ghosh S, Sun L, et al. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects: a double-blind placebo-controlled trial. Thromb Haemost 1995;74:1071-1078
20. Reiter RA, Mayr F, Blazicek H, et al. Desmopressin antagonizes the in vitro platelet dysfunction induced by GpIIb/IIIa inhibitors and aspirin. Blood 2003;102:4594-4599
21. Lethagen S. Desmopressin-a haemostatic drug: state-of-the-art review. Eur J Anaesthesiol Suppl 1997;14:1-9
22. Dickneite G, Metzner H, Pfeifer T, Kroez M, Witzke G. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003;112:73-82
23. Tock B, Drohan W, Hess J, Pusateri A, Holcomb J, MacPhee M. Haemophilia and advanced fibrin sealant technologies. Haemophilia 1998;4:449-455
24. Martinowitz U, Varon D, Jonas P, et al. Circumcision in hemophilia: the use of fibrin glue for local hemostasis. J Urol 1992;148:855-857
25. Brady AP, Malone DE, Diegnan RW, O'Donovan N, McGrath FP. Fibrin sealant in interventional radiology: a preliminary evaluation. Radiology 1995;196:573-578
26. DiMichele DM, Mirani G, Wilfredo Canchis P, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 2003;9:613-618
27. Menzebach A, Cassens U, van Aken H, Booke M. Strategies to reduce perioperative blood loss related to non-surgical bleeding. Eur J Anaesthesiol 2003;20:764-770
28. Key NS. Recombinant FVIIa for intractable hemorrhage: more questions than answers. Transfusion 2003;43:1649-1651
29. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomized trial. Lancet 2003;361: 201-205
30. Deveras RAE, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002;137:884-888
31. Jeffers L, Chalasani N, Balart N, Pyrsopoulos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 2002;123:118-126